| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer | VP, Clinical Development
2 companies
Yu K Peony is a Chief Medical Officer at FIBROGEN INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2018 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 3,422 | $59.20 | $202,582.40 | -2.3% | |
| Apr 16, 2018 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 7,500 | $47.81 | $358,553.00 | -2.4% | |
| Mar 14, 2018 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 9,891 | $53.20 | $526,201.20 | -7.2% | |
| Feb 8, 2018 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 7,500 | $53.97 | $404,778.00 | -2.5% | |
| Jan 29, 2018 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 10,000 | $62.00 | $620,000.00 | -6.2% | |
| Dec 14, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 2,851 | $43.70 | $124,588.70 | -1.7% | |
| Nov 6, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 7,500 | $55.37 | $415,243.50 | -2.2% | |
| Oct 4, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sale+OE | 15,000 | $60.00 | $900,000.00 | -7.9% | |
| Oct 2, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sale+OE | 40,000 | $54.63 | $2,185,000.00 | -9.5% | |
| Sep 14, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 2,851 | $51.00 | $145,401.00 | -1.5% |